JPMorgan retains Tata Capital overweight, sees 12.5% upside to ₹395
JPMorgan maintained its overweight call on Tata Capital, citing potential margin expansion, benign asset quality and 23–25% growth guidance. The brokerage flagged SME exposure and regulatory risk around Flexi products, which account for under 5% of the loan book.
What happened
JPMorgan retained its overweight rating on Tata Capital, citing potential NIM expansion, benign asset quality and 23-25% growth guidance. The brokerage set a Rs
Key facts
- JPMorgan price target: Rs 395
- Implied upside: 12.54%
- Current market price: Rs 351.95
- Growth guidance: 23-25%
- Flexi-product net exposure: below 5% of loan book
- Short-duration funding: 30-60 days
- Credit-cost re-rating threshold: below 1%
Why this matters
Tata Capital’s growth case reinforces the appeal of scaled retail and SME lending, while its limited Flexi exposure—under 5% of loans—highlights the value of disciplined product governance in partnership or acquisition assessments.
What to watch
- Quarterly AUM growth versus 23–25% guidance
- Net interest margin and borrowing-cost trajectory
- GNPA, NNPA and credit-cost movement, especially in SME portfolios
- Flexi-product regulatory developments and any changes in product origination
- Analyst estimate revisions, target-price changes and institutional ownership trends
- Capital adequacy and funding diversification metrics
- Investors may increase scrutiny of quarterly NIM, cost of funds, credit-cost and SME delinquency trends.
- A sustained share-price move toward ₹395 would likely require management to reaffirm growth guidance alongside evidence of stable asset quality.
- Peer NBFC valuations may benefit modestly if Tata Capital demonstrates that growth can coexist with controlled credit costs.
- Management could tilt originations toward lower-risk or higher-yielding segments if regulatory scrutiny of Flexi products intensifies.